Clinical Trial Update: A Study To Evaluate The Effect of T89(Dantonic®)On P450 Enzymes [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate the effect of Dantonic (T89) on cytochrome P450 enzymes in stable angina patients; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina

Drugs mentioned

• Dantonic

Snippet

Sponsor: Tasly Pharmaceuticals, Inc. | Conditions: Stable Angina | Phase 1 | Status: COMPLETED